Amy L Hartman Selected Research

Amy L Hartman Research Topics

Disease

24	Infections 04/2024 - 06/2006
9	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2012
6	COVID-19 04/2024 - 01/2020
4	Inflammation (Inflammations) 10/2022 - 01/2017
4	Virus Diseases (Viral Diseases) 10/2020 - 04/2014
3	Rift Valley Fever 01/2018 - 04/2014
2	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 01/2020
2	Human Influenza (Influenza) 01/2017 - 04/2014
1	Breakthrough Infections 04/2024
1	Measles 04/2024
1	Animal Disease Models 10/2023
1	Equine Encephalomyelitis (Equine Encephalitis) 12/2022
1	Blindness (Hysterical Blindness) 10/2022
1	Cicatrix (Scar) 10/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Vesicular Stomatitis 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Viral Encephalitis 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Fever (Fevers) 11/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Hyperthermia 01/2018
1	Cytokine Release Syndrome 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Influenza in Birds (Avian Flu) 01/2017
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 07/2015

Drug/Important Bio-Agent (IBA)

15	AerosolsIBA 12/2022 - 01/2012
13	VaccinesIBA 04/2024 - 01/2017
5	CytokinesIBA 01/2024 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	Neutralizing AntibodiesIBA 01/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
4	Antiviral Agents (Antivirals)IBA 01/2018 - 07/2006
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	ChemokinesIBA 01/2022 - 01/2021
2	Viral RNAIBA 01/2022 - 10/2020
2	AntibodiesIBA 01/2021 - 03/2008
2	FurinIBA 11/2020 - 06/2020
1	SARS-CoV-2 spike proteinIBA 04/2024
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2023
1	Complementary DNA (cDNA)IBA 12/2022
1	Retinaldehyde (Retinal)IBA 10/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	LigandsIBA 01/2022
1	mouse Lrp1 proteinIBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	glucose-regulated proteinsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	Biological Warfare AgentsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Histocompatibility Antigens Class IIIBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Aligeron (AS 2)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	AlbuminsIBA 01/2017
1	AntigensIBA 01/2017
1	DNA VaccinesIBA 01/2017
1	Prion ProteinsIBA 07/2015
1	favipiravirIBA 04/2014
1	Amino Acids FDA Link 06/2008
1	Sucrose (Saccharose)IBA 06/2008
1	Chemokine CCL5IBA 06/2008
1	Interferon-betaIBA 06/2006

Therapy/Procedure

6	Therapeutics 10/2022 - 01/2018
1	Nebulizers and Vaporizers (Inhaler) 01/2019